Progenics Pharmaceuticals, Inc. Business Finance Contracts & Agreements
16 Contracts & Agreements
- Assignment Agreements (1 contract)
- Loan Agreements (2)
- Purchase Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (7)
- Bridge Loan Agreement, dated as of March 15, 2020, between Progenics Pharmaceuticals, Inc. and Lantheus Medical Imaging, Inc (Filed With SEC on March 16, 2020)
- Description of Capital Stock (Filed With SEC on March 13, 2020)
- Amendment to the Stock Purchase and Sale Agreement, dated May 9, 2019, by and between Progenics Pharmaceuticals, Inc., Molecular Insight Pharmaceuticals, Inc., and Highland... (Filed With SEC on May 14, 2019)
- Underwriting Agreement, dated as of August 7, 2018, by and among Progenics Pharmaceuticals, Inc. and Jefferies LLC and Credit Suisse Securities (USA) LLC, as representatives of... (Filed With SEC on August 10, 2018)
- Loan agreement, dated as of November 4, 2016, by and between Healthcare Royalty Partners III, L.P., as Lender, and MNTX Royalties Sub LLC, as Borrower (Filed With SEC on November 7, 2016)
- Assignment and Assumption Agreement, dated May 6, 2016, between Progenics Pharmaceuticals, Inc., BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc (Filed With SEC on May 10, 2016)
- 7,608,696 Shares Progenics Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on February 21, 2014)
- 8,500,000 Shares Progenics Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on June 21, 2013)
- STOCK PURCHASE AND SALE AGREEMENT BY AND BETWEEN THE STOCKHOLDERS OF MOLECULAR INSIGHT PHARMACEUTICALS, INC. (THE "STOCKHOLDERS") MOLECULAR INSIGHT PHARMACEUTICALS, INC. (THE... (Filed With SEC on May 10, 2013)
- 11,000,000 Shares Progenics Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on November 30, 2012)
- MEMBERSHIP INTEREST PURCHASE AGREEMENT by and between PROGENICS PHARMACEUTICALS, INC. and CYTOGEN CORPORATION Dated April 20, 2006 TABLE OF CONTENTS (Filed With SEC on August 8, 2006)
- Progenics Pharmaceuticals, Inc. 2,500,000 Shares Common Stock ($0.0013 par value) Underwriting Agreement (Filed With SEC on September 15, 2005)
- Progenics Pharmaceuticals, Inc. 1,532,467 Shares Common Stock ($0.0013 par value) Underwriting Agreement (Filed With SEC on June 13, 2005)
- Progenics Pharmaceuticals, Inc. 2,000,000 Shares Common Stock ($0.0013 par value) Underwriting Agreement (Filed With SEC on April 5, 2005)
- PROGENICS PHARMACEUTICALS, INC. RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on January 14, 2005)
- PROGENICS PHARMACEUTICALS, INC. Non-Qualified Stock Option Agreement Option Certificate Number: (Filed With SEC on January 14, 2005)